You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pemigatinib

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

Recruiting
  • Solid Tumor
  • +4 more
  • Pemigatinib
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 28, 2023

Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)

Recruiting
  • Carcinoma
  • +4 more
  • Pemigatinib
  • PD-1 Inhibitors
  • Guangzhou, Guangdong, China
    Lei Zhang
Jun 21, 2023

Gastrointestinal Cancer Trial in Tianjin (Pemigatinib)

Recruiting
  • Gastrointestinal Cancer
  • Pemigatinib
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Dec 7, 2022

Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)

Not yet recruiting
  • Advanced Intrahepatic Cholangiocarcinoma
  • Pemigatinib
  • (no location specified)
Sep 30, 2022

Cholangiocarcinoma Trial in Shanghai (Pemigatinib)

Active, not recruiting
  • Cholangiocarcinoma
  • Pemigatinib
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Oct 3, 2022

NSCLC Trial in Suzhou (Pemigatinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Pemigatinib
  • Suzhou, China
    The First Affiliated Hospital of Soochow University
Jan 14, 2022

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR1 Gene Translocation Trial in United States (Pemigatinib, Quality-of-Life

Active, not recruiting
  • FGFR1 Gene Amplification
  • +18 more
  • Pemigatinib
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +5 more
Oct 18, 2022

Advanced NSCLC Trial in Xiamen (Pemigatinib)

Recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Pemigatinib
  • Xiamen, Fujian, China
    the First Affiliated Hospital of Xiamen University
Mar 10, 2022

Urothelial Cancer Trial in Italy (Pemigatinib)

Active, not recruiting
  • Urothelial Cancer
  • Pemigatinib
  • Bergamo, Italy
  • +4 more
Jan 25, 2022

Advanced Malignancies Trial in Worldwide (Pemigatinib, Retifanlimab, Pembrolizumab)

Recruiting
  • Advanced Malignancies
  • Pemigatinib
  • +2 more
  • Santa Monica, California
  • +6 more
Apr 6, 2022

Gastric and Colorectal Cancer Trial in Wuhan (pemigatinib)

Recruiting
  • Gastric and Colorectal Cancer
  • pemigatinib
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Jan 9, 2022

Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Unresectable Cholangiocarcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Cholangiocarcinoma
  • +2 more
  • Scottsdale, Arizona
  • +7 more
Jun 24, 2022

Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Cancer
  • Pemigatinib
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Aug 11, 2023

Solid Tumor Trial in Tianjin (Pemigatinib)

Completed
  • Solid Tumor
  • Pemigatinib
  • Tianjin, China
    Cancer Hospital of Tianjin Medical University
Jul 22, 2021

Advanced Non Small Cell Lung Cancer Trial (Sintilimab, Pemigatinib)

Not yet recruiting
  • Advanced Non Small Cell Lung Cancer
  • (no location specified)
Aug 6, 2021

MPN (Myeloproliferative Tumors) Trial in Worldwide (Pemigatinib)

Active, not recruiting
  • MPN (Myeloproliferative Neoplasms)
  • Pemigatinib
  • Phoenix, Arizona
  • +32 more
Jun 24, 2022

NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Pemigatinib
  • Los Angeles, California
  • +41 more
Jun 27, 2022

Cholangiocarcinoma Trial in Worldwide (Pemigatinib)

Completed
  • Cholangiocarcinoma
  • Pemigatinib
  • Anchorage, Alaska
  • +119 more
Apr 4, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Pemigatinib
  • +5 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022

Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

Recruiting
  • Glioblastoma
  • Adult-type Diffuse Gliomas
  • Pemigatinib
  • Beverly Hills, California
  • +83 more
Jul 25, 2022

UC (Urothelial Cancer) Trial in Worldwide (pemigatinib)

Completed
  • UC (Urothelial Cancer)
  • pemigatinib
  • Tucson, Arizona
  • +95 more
Feb 28, 2022

Solid Tumor Malignancy Trial in Worldwide (Pemigatinib)

Terminated
  • Solid Tumor Malignancy
  • Pemigatinib
  • Goodyear, Arizona
  • +89 more
Jun 14, 2022

Solid Tumors Trial in Japan (Pemigatinib)

Completed
  • Solid Tumors
  • Pemigatinib
  • Aichi, Japan
  • +11 more
May 27, 2020

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (Pemigatinib, Gemcitabine, Cisplatin)

Recruiting
  • Unresectable Cholangiocarcinoma
  • Metastatic Cholangiocarcinoma
  • Pemigatinib
  • +2 more
  • Phoenix, Arizona
  • +212 more
Nov 15, 2022